Actelion SWOT Analysis, USP & Competitors

Posted in Pharmaceuticals and Healthcare, Total Reads: 2890
Advertisements

SWOT Analysis of Actelion with USP, Competition, STP (Segmentation, Targeting, Positioning) - Marketing Analysis

Actelion

Parent Company

Actelion

Category

Pharmaceutical

Sector

Healthcare

Tagline/ Slogan

Together we innovate

USP

Actelion operates in niche segment of orphan diseases

STP

Segment

Orphan diseases such as digital ulcers, gaucher’s disease

Target Group

Healthcare professionals operating in these areas

Positioning

Actelion is company which blends biotechnological innovation with pharmaceutical discipline

SWOT Analysis

Strengths

1. Actelion operates in niche segment of orphan diseases which have less competition

2. Strong presence in over 60 plus markets

3. Key drugs in the late stages of development in pipeline

4. Longer patent life of key drugs

5. Over 2500+ well trained employees

Weaknesses

1. Limited presence in emerging markets

2. They have only four blockbuster drugs

Opportunities

1. Diversify portfolio in specialty diseases

2. Contract manufacturing of G.P diseases

3. Market introduction of Cadazolid

Threats

1. Increasing pressure to reduce prices in Europe

2. Growing number of generic drugs

3. Global economic slowdown

Competition

Competitors

1. Abbott laboratories
2. Amicus therapeutics Inc

3. Aradigm corporation

4. AstraZeneca



Advertisements



Looking for More Brands? Search BrandGuide

Edit the Brand or Add a New One : Contribute to BrandGuide

The brandnames and other brand information used in the brandguide section are properties of their respective companies. The companies are not associated with MBASkool in any way. The brand names are used purely for educational/academic purpose only.
Utmost Care has been taken in the analysis of the brands. However, if you find any ambiguity kindly help us improve.